News
NBSE
0.3780
0.00%
0.00
Weekly Report: what happened at NBSE last week (0527-0531)?
Weekly Report · 06/03 11:20
Weekly Report: what happened at NBSE last week (0520-0524)?
Weekly Report · 05/27 11:25
Weekly Report: what happened at NBSE last week (0513-0517)?
Weekly Report · 05/20 11:18
Weekly Report: what happened at NBSE last week (0506-0510)?
Weekly Report · 05/13 11:30
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 05/06 12:06
Weekly Report: what happened at NBSE last week (0429-0503)?
Weekly Report · 05/06 11:37
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 05/03 20:31
NEUBASE THERAPEUTICS INC - ON MAY 2, NASDAQ NOTIFIED COMPANY THAT IT HAS NOT REGAINED COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT
Reuters · 05/03 20:01
NEUBASE THERAPEUTICS - EXPECTS TRADING IN CO'S COMMON STOCK WILL BE SUSPENDED UPON OPENING OF BUSINESS ON MAY 13
Reuters · 05/03 20:01
Weekly Report: what happened at NBSE last week (0422-0426)?
Weekly Report · 04/29 11:44
Weekly Report: what happened at NBSE last week (0415-0419)?
Weekly Report · 04/22 11:32
Weekly Report: what happened at NBSE last week (0408-0412)?
Weekly Report · 04/15 11:23
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 04/12 20:31
Weekly Report: what happened at NBSE last week (0401-0405)?
Weekly Report · 04/08 11:28
NeuBase Therapeutics Received A Notice On April 4, 2024 From The Listing Qualifications Department Of The Nasdaq Stock Market Notifying The Company That It Was Not In Compliance With Nasdaq's Continued Listing Requirements Under Nasdaq Listing Rule 5250(c)(1)
Benzinga · 04/05 20:09
NEUBASE THERAPEUTICS ANNOUNCES RECEIPT OF NOTICE FROM NASDAQ
Reuters · 04/05 20:06
Weekly Report: what happened at NBSE last week (0325-0329)?
Weekly Report · 04/01 11:25
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Benzinga · 03/26 18:43
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 03/26 17:45
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 03/26 17:31
More
Webull provides a variety of real-time NBSE stock news. You can receive the latest news about Neubase Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About NBSE
NeuBase Therapeutics, Inc. is a preclinical-stage biotechnology company. It is developing a modular peptide-nucleic acid (PNA) antisense oligo (PATrOL) platform to address genetic diseases, with a single, cohesive approach. The Company’s programs are NT-0100 in HD, NT-0200 in myotonic dystrophy type 1 (DM1) and NT-0300 in KRAS-driven cancers. The NT-0100 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the HD DNA or RNA. The NT-0200 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the DM1 disease RNA. The NT-0300 program is a PATrOL-enabled therapeutic program being developed to target the mutated KRAS gene. It uses its platform to address diseases which have a genetic source, with an initial focus on gene silencing in DM1, Huntington’s disease (HD), and oncology and in gene editing applications. It also focused on identifying and evaluating multiple indications for potential development.